The Impact of HIV on Women in the United States
This factsheet provides an overview of the impact of HIV on women in the U.S.
Read More
Which Platform of Platforms (UDHP) is Right for your Health System? A Market Analysis
Neil Jennings Vince Kuraitis By NEIL JENNINGS & VINCE KURAITIS This entry is part 5 of 5 in the series Platforming Healthcare — The Long View In previous posts in this series, we have covered the definitions of Unified Digital Health platforms and whether “EHRs can become UDHPs.” In this follow-on post, we’ll talk through the requirements for…
CVS Health Exec: We Need a Better Definition of What Good Looks Like in Behavioral Health
Behavioral health needs a clearer definition of quality care, which may require policy action, according to Dr. Taft Parsons of CVS Health. The post CVS Health Exec: We Need a Better Definition of What Good Looks Like in Behavioral Health appeared first on MedCity News.
Hidden in Plain Sight: How Existing Hospital Technology Can Prevent Workplace Violence
Beyond the human cost, workplace violence carries significant economic consequences for healthcare institutions. Addressing this issue through virtual technology represents not just an ethical imperative but a financial one. The post Hidden in Plain Sight: How Existing Hospital Technology Can Prevent Workplace Violence appeared first on MedCity News.
Recortes de Trump a Medicaid apuntaban a “adultos sanos”, pero hospitales advierten que niños sufrirán las consecuencias
Los republicanos insisten en que los recortes del presidente Donald Trump a Medicaid buscaban reducir el fraude y poner a trabajar a más adultos beneficiarios del programa. Pero los efectos secundarios pueden incluir menos atención médica para niños enfermos. Algunos hospitales infantiles podrían perder miles de millones de dólares en ingresos una vez que se…
Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes. But the topline results don’t show an advantage over Eli Lilly’s commercialized obesity medication, Zepbound. The post Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss…
How Much do People with Employer Plans Spend Out-of-Pocket on Cost-Sharing??
This Peterson-KFF Health System Tracker chart collection examines trends in employee spending on deductibles, copayments, and coinsurance from 2012 to 2023 using a sample of health benefit claims for individuals under 65.
FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer
AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of mantle cell lymphoma. The regulatory decision makes Calquence the first BTK inhibitor approved as an initial treatment for this type of blood cancer. The post FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer appeared…
6 Care Navigation/Care Coordination Startups Aimed at Consumers/Employers to Watch
At the MedCity INVEST conference May 20-21 in Chicago, the startups will take part in the Pitch Perfect contest, pitching their technology and services to investor judges. The post 6 Care Navigation/Care Coordination Startups Aimed at Consumers/Employers to Watch appeared first on MedCity News.
Don’t Erode Medical Device Trust with Right to Repair
Right to repair would undermine the FDA’s regulations and introduce unnecessary risk into the healthcare industry, threatening the high-quality care that doctors provide patients. The post Don’t Erode Medical Device Trust with Right to Repair appeared first on MedCity News.